Our History

2011
Bavla facility for the production of Highly Potent API will be completed and fully operational.
Shanghai facility upgrade for high containment completed

2010
Shanghai API production facility completes qualification

2007
Formation of Dishman Japan.
Acquisition of Solvay Vitamins and Chemicals business based in the Netherlands.

2006
Acquisition of CARBOGEN AMCIS, Swiss-based Contract Research and Manufacturing Organisation.
Formation of Dishman China.

2005
Acquisition of IO3S, Swiss-based ozone technology specialists.

2004
Dishman IPO on Indian Stock Exchange.

2001
First commercial contract manufacturing agreement signed with a major western pharmaceutical company.

1998
Establishment of Dishman Europe and Dishman USA sales subsidiaries.

1996
Initiation of Bavla facility for bulk intermediates.

1995
Formation of a joint venture company with Schütz & Co., called Schütz Dishman Biotech Private Ltd.
Manufacture of chlorhexidine and derivates for European market.

1989
Production of a range of phase transfer catalysts and quats at Naroda facility.

1983 
Incorporation of Dishman Pharmaceuticals and Chemicals Limited.